Location History:
- Laval, CA (2008)
- Montréal, CA (2013)
Company Filing History:
1 out of 1 
1 out of 2 
1 out of 1 Years Active: 2008-2013
Title: Martin Beauchamp: Innovator in Cytokine Receptor Modulation
Introduction
Martin Beauchamp is a notable inventor based in Montréal, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic peptides and cytokine receptor modulators. With a total of two patents to his name, Beauchamp's work focuses on innovative treatments for various inflammatory diseases.
Latest Patents
Beauchamp's latest patents include "Interleukin-1 receptor antagonists, compositions, and methods of treatment" and "Cytokine receptor modulators and method of modulating cytokine receptor activity." The first patent discloses peptides designed to inhibit the biological activity of the IL-1R type 1 receptor, which is crucial in treating IL-1 related diseases such as arthritis and inflammatory bowel disease. The second patent outlines a method for identifying non-competitive peptides that inhibit cytokine receptor activity, providing potential treatments for autoimmune and vascular diseases.
Career Highlights
Throughout his career, Martin Beauchamp has worked with various companies, including Valorisation-Recherche Société En Commandite and Valorisation Hsj, Société En Commandite. His innovative approaches have positioned him as a key figure in the biotechnology sector, contributing to advancements in therapeutic solutions.
Collaborations
Beauchamp has collaborated with notable professionals in his field, including Sylvain Chemtob and Christiane Quiniou. These partnerships have further enhanced his research and development efforts, leading to impactful innovations.
Conclusion
Martin Beauchamp's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for new treatments in the realm of inflammatory diseases.